IPXL Related Earnings News

May 1, 2013 04:22 PM Impax Laboratories Inc. (IPXL) Tops Q1 EPS by 16c

Feb 25, 2013 04:02 PM Impax Laboratories Inc. (IPXL) Tops Q4 EPS by 4c

Oct 31, 2012 02:13 PM Impax Laboratories (IPXL) Story Intact Despite Bruising

Oct 30, 2012 08:20 AM UPDATE: Impax Laboratories (IPXL) Posts Q3 EPS of 48c; Sees Q4 Revs Down 15% - 20%

Aug 1, 2012 09:18 AM Canaccord Genuity Reiterates a 'Buy' on Impax Laboratories (IPXL); Stock Can Run with 2H Catalysts

Aug 1, 2012 08:43 AM Needham & Company Maintains a 'Hold' on Impax Laboratories (IPXL); Concentrating Hard...On FDA Warning Letter Effects

Jul 31, 2012 07:13 AM Impax Laboratories Inc. (IPXL) Tops Q2 EPS by 16c

Jul 6, 2012 08:25 AM Goldman Cuts Price Target on Impax (IPXL) to $19 as Competition Looms

Jun 25, 2012 08:08 AM Jefferies Lowers Numbers on Impax Laboratories (IPXL)

May 14, 2012 10:17 AM Auriga Reiterates a 'Buy' on Impax Laboratories (IPXL); Positive After Meetin with Management

May 2, 2012 09:02 AM Needham & Company Maintains a 'Hold' on Impax Laboratories (IPXL); Clearing Q1 Hurdle; Regulatory Clouds Remain

May 1, 2012 08:26 AM Needham & Company Maintains a 'Strong Buy' on Mylan (MYL); Chalk One Up in the PIV Win Column As Doryx Goes Generic

May 1, 2012 07:25 AM Impax Laboratories Inc. (IPXL) Tops Q1 EPS by 3c

Apr 30, 2012 05:49 PM Warner Chilcott (WCRX) Says Generic Doryx Doesn't Violate '161 Patent, Sees FY12 Impairment Charge of $90-$108M

Apr 26, 2012 10:45 AM Auriga Maintains a 'Buy' on Impax Laboratories (IPXL); Generic Adderall XR Sales In-Line

Apr 19, 2012 10:07 AM Canaccord Genuity on Specialty Pharmaceutical: Top Picks Have Less Volatility With Earnings

Feb 29, 2012 01:13 PM UBS Maintains a 'Neutral' on Impax Laboratories (IPXL); Getting Ready for a Busy Year Ahead

Feb 29, 2012 11:16 AM Canaccord Genuity Reiterates a 'Buy' on Impax Laboratories (IPXL); Near-Term Path Still Vatalyst-Heavy

Feb 29, 2012 09:55 AM Jefferies Raises Numbers On Impax Laboratories (IPXL) After Strong Q4; Maintains Hold Rating

Feb 28, 2012 07:04 AM Impax Laboratories Inc. (IPXL) Reports Q4 EPS of $0.33, Sales Top Expectations

Feb 1, 2012 08:07 AM Impax (IPXL) Unit Licenses Zomig Rights in U.S. from AstraZeneca (AZN); Updates FY12 Outlook

Nov 1, 2011 07:06 AM Impax Laboratories Inc. (IPXL) Tops Q3 EPS by 7c; Revs Light

Aug 2, 2011 07:20 AM Impax Laboratories (IPXL) Tops Q2 EPS by 3c, Revenue Beats Expectations

May 3, 2011 07:05 AM Impax Laboratories Inc. (IPXL) Tops Q1 EPS by 9c

Feb 24, 2011 07:03 AM Impax Laboratories Inc. (IPXL) Reports In-Line Q4 EPS

Nov 2, 2010 08:07 AM Impax Labs (IPXL) Posts Q3 EPS of $0.24, Shy of Views

May 4, 2010 08:20 AM Impax Labs (IPXL) Posts Q1 EPS of $2.06, Beats Views

Feb 25, 2010 07:47 AM Impax Labs (IPXL) Blows-Out Q4 Results: Adj-EPS of $0.69 on Sales of $176.1M

May 5, 2009 10:19 AM Impax Laboratories (IPXL) Profits Up on 18% Jump In Revenue